TRIM33 and dermatomyositis: DM patients were further divided into MSA subgroups which showed that patients with anti-Jo1 and anti-MDA5 antibodies had significantly higher ICAM-1 and VCAM-1 levels compared to both healthy controls and anti-TIF1gamma positive DM patients (Fig. 1).